Bionomics Limited

200 Greenhill Road

Eastwood, SA 5063

Australia

 

June 24, 2024

 

via EDGAR 

 

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, DC 20549

Attention: Chris Edwards

 

Re:	Bionomics Limited

Registration Statement on Form F-1

Filed June 18, 2024

Securities Act File No. 333-280288

 

Request for Acceleration of Effectiveness

 

Dear Mr. Edwards:

 

Pursuant to Rule 461 of Regulation C under the Securities Act of 1933, as amended, Bionomics Limited (the “Registrant”) respectfully requests acceleration of its Registration Statement on Form F-1 (File No. 333-280288), filed on June 18, 2024, so that it will become effective at 9:00 a.m. (Eastern time) on June 26, 2024, or as soon as practicable thereafter.

 

If you have any questions, or require any additional information, please do not hesitate to email Theodore Ghorra, the Registrant’s outside counsel, at theodore.ghorra@rimonlaw.com or by phone at 212-515-9979.

 

The Registrant acknowledges that, if the Securities and Exchange Commission (or its staff, acting pursuant to delegated authority) (the “Commission”) declares the filing effective, such action:

 

(i)

does not foreclose the Commission from taking any action with respect to the filing;

 

(ii)

does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

 

(iii)

may not be asserted by the Registrant as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

 

Very truly yours,
Bionomics Limited
By:	/s/ Spyridon Papapetropoulos
	Spyridon Papapetropoulos, M.D.
	Chief Executive Officer

 

cc:	Theodore J. Ghorra, Esq., Rimon P.C.

Andrew Reilly, Esq., Rimon P.C.